Tifft CJ - Search Results

1

Glb1 knockout mouse model shares natural history with type II GM1 gangliosidosis patients.

Nicoli ER, Huebecker M, Han ST, Garcia K, Munasinghe J, Lizak M, Latour Y, Yoon R, Glase B, Tyrlik M, Peiravi M, Springer D, Baker EH, Priestman D, Sidhu R, Kell P, Jiang X, Kolstad J, Kuhn AL, Shazeeb MS, Acosta MT, Proia RL, Platt FM, Tifft CJ. Nicoli ER, et al. Among authors: tifft cj. Mol Genet Metab. 2023 Feb;138(2):107508. doi: 10.1016/j.ymgme.2023.107508. Epub 2023 Jan 13. Mol Genet Metab. 2023. PMID: 36709532 Free PMC article.

2

The folding and cell surface expression of CD4 requires glycosylation.

Tifft CJ, Proia RL, Camerini-Otero RD. Tifft CJ, et al. J Biol Chem. 1992 Feb 15;267(5):3268-73. J Biol Chem. 1992. PMID: 1737783 Free article.

3

Synthesis of a human lysosomal enzyme, beta-hexosaminidase B, using the baculovirus expression system.

Boose JA, Tifft CJ, Proia RL, Myerowitz R. Boose JA, et al. Among authors: tifft cj. Protein Expr Purif. 1990 Nov;1(2):111-20. doi: 10.1016/1046-5928(90)90003-h. Protein Expr Purif. 1990. PMID: 1967020

4

Identification of domains in human beta-hexosaminidase that determine substrate specificity.

Pennybacker M, Liessem B, Moczall H, Tifft CJ, Sandhoff K, Proia RL. Pennybacker M, et al. Among authors: tifft cj. J Biol Chem. 1996 Jul 19;271(29):17377-82. doi: 10.1074/jbc.271.29.17377. J Biol Chem. 1996. PMID: 8663217 Free article.

5

Mice lacking both subunits of lysosomal beta-hexosaminidase display gangliosidosis and mucopolysaccharidosis.

Sango K, McDonald MP, Crawley JN, Mack ML, Tifft CJ, Skop E, Starr CM, Hoffmann A, Sandhoff K, Suzuki K, Proia RL. Sango K, et al. Among authors: tifft cj. Nat Genet. 1996 Nov;14(3):348-52. doi: 10.1038/ng1196-348. Nat Genet. 1996. PMID: 8896570

6

The beta-hexosaminidase deficiency disorders: development of a clinical paradigm in the mouse.

Tifft CJ, Proia RL. Tifft CJ, et al. Ann Med. 1997 Dec;29(6):557-61. doi: 10.3109/07853899709007482. Ann Med. 1997. PMID: 9562524 Review.

7

Bone marrow transplantation prolongs life span and ameliorates neurologic manifestations in Sandhoff disease mice.

Norflus F, Tifft CJ, McDonald MP, Goldstein G, Crawley JN, Hoffmann A, Sandhoff K, Suzuki K, Proia RL. Norflus F, et al. Among authors: tifft cj. J Clin Invest. 1998 May 1;101(9):1881-8. doi: 10.1172/JCI2127. J Clin Invest. 1998. PMID: 9576752 Free PMC article.

8

Microglial activation precedes acute neurodegeneration in Sandhoff disease and is suppressed by bone marrow transplantation.

Wada R, Tifft CJ, Proia RL. Wada R, et al. Among authors: tifft cj. Proc Natl Acad Sci U S A. 2000 Sep 26;97(20):10954-9. doi: 10.1073/pnas.97.20.10954. Proc Natl Acad Sci U S A. 2000. PMID: 11005868 Free PMC article.

9

Enhanced survival in Sandhoff disease mice receiving a combination of substrate deprivation therapy and bone marrow transplantation.

Jeyakumar M, Norflus F, Tifft CJ, Cortina-Borja M, Butters TD, Proia RL, Perry VH, Dwek RA, Platt FM. Jeyakumar M, et al. Among authors: tifft cj. Blood. 2001 Jan 1;97(1):327-9. doi: 10.1182/blood.v97.1.327. Blood. 2001. PMID: 11133779 Free article.

10

Stemming the tide: glycosphingolipid synthesis inhibitors as therapy for storage diseases.

Tifft CJ, Proia RL. Tifft CJ, et al. Glycobiology. 2000 Dec;10(12):1249-58. doi: 10.1093/glycob/10.12.1249. Glycobiology. 2000. PMID: 11159916 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

207 results

Search Page